FENTON DENNIS M 4/A
4/A · First Tracks Biotherapeutics, Inc. · Filed Jun 12, 2026
Research Summary
AI-generated summary of this filing
First Tracks (TRAX) Director Dennis Fenton Receives Options & RSUs
What Happened Dennis M. Fenton, a director of First Tracks Biotherapeutics, was granted equity awards on May 12, 2026: 7,000 stock options and 2,500 restricted stock units (RSUs). Both grants are recorded as derivative awards (code A) at $0.00 acquisition price in the Form 4 amendment. The filing amends the original Form 4 to correct the award amounts.
Key Details
- Transaction date: May 12, 2026 (reported via amended Form 4 filed June 12, 2026; original Form 4 was filed May 14, 2026).
- Awards: 7,000 stock options; 2,500 RSUs. Reported acquisition price: $0.00 (award).
- Shares owned after transaction: Not disclosed in this filing.
- Vesting / footnotes:
- RSUs (F1/F2): Each RSU converts to one share at settlement for no consideration; 100% of the RSUs vest on the issuer’s 2027 annual meeting date, subject to continued service.
- Stock options (F3): Vesting occurs 1/12 of the total monthly beginning June 12, 2026 until fully vested, subject to continued service.
- Filing status: This is an amended Form 4 correcting the originally reported award amounts.
Context These are non-cash equity awards (grant/award), not open-market purchases or sales. RSUs convert to shares upon vesting/settlement; options will vest monthly per the schedule and require exercise to convert to shares (exercise price not stated in this filing). Amended filings like this correct prior reporting but do not by themselves indicate buying or selling activity.
Insider Transaction Report
- Award
Restricted Stock Unit
[F1][F2]2026-05-12+2,500→ 2,500 total→ Common Stock (2,500 underlying) - Award
Stock Option (right to buy)
[F3]2026-05-12+7,000→ 7,000 totalExercise: $17.81Exp: 2036-05-11→ Common Stock (7,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
- [F2]The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- [F3]The stock option vests as to 1/12 of the total shares monthly commencing on June 12, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.